23andMe News - ME

Company Name	Stock Ticker Symbol	Market	Type
23andMe Holding Company	ME	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.0106	2.31%	0.4696	00:00:02

Open Price	Low Price	High Price	Close Price	Prev Close
0.455	0.4502	0.4788	0.4641	0.459

more quote information »

Recent News

Date	Time	Source	Heading
4/24/2024	16:05	GLOBE	23andMe to Present Preliminary Efficacy and Biomarker Data..
4/18/2024	08:00	GLOBE	23andMe announces CEO’s intention to pursue a potential..
4/05/2024	16:05	GLOBE	23andMe to Present Data on Two Clinical Stage..
3/20/2024	07:30	GLOBE	23andMe Initiates Phase 1 Clinical Trial for its Dual..
3/19/2024	08:00	GLOBE	23andMe Launches New Feature Connecting Customers to..
3/06/2024	07:30	GLOBE	23andMe Launches New Genetic Reports on Common Forms of..
3/05/2024	16:30	GLOBE	23andMe Announces Three Presentations from Clinical-Stage..
2/21/2024	16:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/07/2024	16:07	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/07/2024	16:03	EDGAR2	Form 8-K - Current report
2/07/2024	16:01	GLOBE	23andMe Reports Third Quarter Fiscal 2024 Financial Results
2/06/2024	07:00	BW	Moneta Gold and Nighthawk Gold Complete At-Market Merger to..
1/31/2024	07:50	EDGAR2	Form 8-K - Current report
1/30/2024	22:12	GLOBE	23andMe Launches Month-Long Initiative to Amplify ARRAY’s..
1/30/2024	17:00	BW	Nighthawk Gold Obtains Final Court Order for the Proposed..
1/24/2024	16:05	GLOBE	23andMe to Report FY2024 Third Quarter Financial Results
1/22/2024	08:00	BW	Moneta Gold and Nighthawk Gold Announce the Proposed..
1/08/2024	07:45	EDGAR2	Form 8-K - Current report
12/19/2023	08:00	GLOBE	23andMe announces further expansion of 23ME-00610 Phase 1/2a..
12/01/2023	16:06	EDGAR2	Form 8-K/A - Current report: [Amend]
11/28/2023	07:15	BW	Nighthawk and Moneta Announce At-Market Merger to Create a..
11/21/2023	16:41	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/21/2023	16:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/13/2023	16:06	EDGAR2	Form 8-K - Current report
11/08/2023	16:29	EDGAR2	Form 8-K - Current report
11/08/2023	16:05	GLOBE	23andMe Reports Second Quarter Fiscal 2024 Financial Results
11/07/2023	08:00	GLOBE	23andMe Launches Total Health™, its..
11/06/2023	08:15	EDGAR2	Form 8-K - Current report
11/06/2023	08:00	GLOBE	23andMe Announces Updated Safety and Preliminary Efficacy..
10/31/2023	08:00	GLOBE	23andMe Launches Health Action Plan to Provide Personalized..
10/30/2023	16:05	EDGAR2	Form 8-K - Current report
10/30/2023	08:00	GLOBE	23andMe Announces Collaboration Extension with a New Data..
10/27/2023	16:06	EDGAR2	Form 8-K - Current report
10/25/2023	16:05	GLOBE	23andMe to Report FY2024 Second Quarter Financial Results
10/10/2023	16:17	EDGAR2	Form 8-K - Current report
9/27/2023	16:05	GLOBE	23andMe Announces Poster Presentations on 23ME-00610, an..
9/19/2023	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/19/2023	16:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/19/2023	16:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/19/2023	16:06	EDGAR2	Form 8-K - Current report
9/15/2023	16:06	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
9/14/2023	07:00	GLOBE	23andMe and Sickle Cell 101 Collaborate to Expand Sickle..
9/11/2023	16:06	EDGAR2	Form 8-K - Current report
9/08/2023	16:55	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/08/2023	16:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/06/2023	17:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/05/2023	18:30	EDGAR2	Form 144 - Report of proposed sale of securities
8/31/2023	17:28	GLOBE	23andMe Granted New FDA Clearance to Report Additional BRCA..
8/22/2023	16:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/22/2023	16:22	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..